Search research articles
Contact Us
Filters
Showing results (541-550 of 686) with videos related to
Page
of 69
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 19, 2019
Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity
John Marshall, Jennifer B Nietupski, Hyejung Park, et al.
Leukemia & Lymphoma
|
April 10, 2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma
Sarah C Rutherford, Biree Andemariam, Shibu M Philips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2007
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma
John P Leonard, Brian K Link, Christos Emmanouilides, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 18, 2012
Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L
Montserrat Cols, Carolina M Barra, Bing He, et al.
Cancer Medicine
|
December 22, 2018
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials
Frederick Lansigan, Ian Barak, Brandelyn Pitcher, et al.
Journal of Child Neurology
|
October 28, 2008
Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas
Bernard L Maria, Nalin Gupta, Anne G Gilg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II results
Franck Morschhauser, John P Leonard, Luis Fayad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)
Ann S LaCasce, Travis Dockter, Amy S Ruppert, et al.
Journal of the American Chemical Society
|
September 6, 2018
Insights on the Proton Insertion Mechanism in the Electrode of Hexagonal Tungsten Oxide Hydrate
Heng Jiang, Jessica J Hong, Xianyong Wu, et al.
Haematologica
|
February 24, 2018
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort
Lisa M Rimsza, Hongli Li, Rita M Braziel, et al.
Page
of 69
Search research articles
Search
Showing results (541-550 of 686) with videos related to
Sort By:
Page
of 69
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 19, 2019
Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity
John Marshall, Jennifer B Nietupski, Hyejung Park, et al.
Leukemia & Lymphoma
|
April 10, 2008
FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma
Sarah C Rutherford, Biree Andemariam, Shibu M Philips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2007
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma
John P Leonard, Brian K Link, Christos Emmanouilides, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 18, 2012
Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L
Montserrat Cols, Carolina M Barra, Bing He, et al.
Cancer Medicine
|
December 22, 2018
The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials
Frederick Lansigan, Ian Barak, Brandelyn Pitcher, et al.
Journal of Child Neurology
|
October 28, 2008
Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas
Bernard L Maria, Nalin Gupta, Anne G Gilg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II results
Franck Morschhauser, John P Leonard, Luis Fayad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)
Ann S LaCasce, Travis Dockter, Amy S Ruppert, et al.
Journal of the American Chemical Society
|
September 6, 2018
Insights on the Proton Insertion Mechanism in the Electrode of Hexagonal Tungsten Oxide Hydrate
Heng Jiang, Jessica J Hong, Xianyong Wu, et al.
Haematologica
|
February 24, 2018
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort
Lisa M Rimsza, Hongli Li, Rita M Braziel, et al.
Page
of 69